Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

STRATA Skin Sciences (SSKN) Notes Payables (2016 - 2021)

STRATA Skin Sciences' Notes Payables history spans 7 years, with the latest figure at $7.3 million for Q2 2021.

  • On a quarterly basis, Notes Payables changed 0.0% to $7.3 million in Q2 2021 year-over-year; TTM through Jun 2021 was $7.3 million, a 0.0% change, with the full-year FY2020 number at $7.3 million, changed 0.0% from a year prior.
  • Notes Payables hit $7.3 million in Q2 2021 for STRATA Skin Sciences, roughly flat from $7.3 million in the prior quarter.
  • Over the last five years, Notes Payables for SSKN hit a ceiling of $7.3 million in Q4 2019 and a floor of $34000.0 in Q3 2017.
  • Historically, Notes Payables has averaged $4.0 million across 5 years, with a median of $7.3 million in 2019.
  • Biggest five-year swings in Notes Payables: soared 47.31% in 2017 and later plummeted 62.77% in 2018.
  • Tracing SSKN's Notes Payables over 5 years: stood at $357000.0 in 2017, then crashed by 85.71% to $51000.0 in 2018, then surged by 14164.71% to $7.3 million in 2019, then changed by 0.0% to $7.3 million in 2020, then changed by 0.0% to $7.3 million in 2021.
  • Business Quant data shows Notes Payables for SSKN at $7.3 million in Q2 2021, $7.3 million in Q1 2021, and $7.3 million in Q4 2020.